tau

positive negative up down good bad mixed
Biotech

Biogen advances Alzheimer’s tau program despite midphase miss

While the study failed to yield the hoped-for dose-response data, reductions in tau and cognitive benefits led Biogen to commit to a pivotal trial.
Nick Paul Taylor May 14, 2026 8:35am
Two mice on the rotarod test

Oligomerix small molecule tamps down tau tangles in mice

Mar 14, 2025 12:30pm
arrow back backwards u-turn turn around reverse

Roche tosses out $120M tau prospect, returning rights to UCB

Oct 22, 2024 8:30am
Cutting a rope knot

Potential new Alzheimer's drugs target tangles of tau

Sep 19, 2024 2:42pm
blood test

Quanterix launches prescription blood test for Alzheimer's

Jul 10, 2023 9:54am
Head with brain in cupped hand

Proclara gets $47M to target protein misfolding in Alzheimer’s

Sep 7, 2016 7:00am